MENU
+Compare
HROW
Stock ticker: NASDAQ
AS OF
Jan 23, 04:40 PM (EDT)
Price
$33.56
Change
-$0.99 (-2.87%)
Capitalization
467.85M

HROW Harrow Forecast, Technical & Fundamental Analysis

a pharmaceutical company

HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HROW with price predictions
Jan 08, 2025

HROW's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HROW turned positive on December 26, 2024. Looking at past instances where HROW's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Indicator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on HROW as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HROW advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HROW entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HROW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.398) is normal, around the industry mean (58.527). P/E Ratio (39.526) is within average values for comparable stocks, (90.460). HROW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.207) is also within normal values, averaging (19.547).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HROW is expected to report earnings to fall 210.42% to 13 cents per share on March 13

Harrow HROW Stock Earnings Reports
Q4'24
Est.
$0.13
Q3'24
Missed
by $0.07
Q2'24
Beat
by $0.12
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.22
The last earnings report on November 13 showed earnings per share of -11 cents, missing the estimate of -5 cents. With 135.99K shares outstanding, the current market capitalization sits at 467.85M.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVFX12.38N/A
N/A
Hartford International Equity F
RYHAX36.03-0.01
-0.03%
Rydex Health Care H
HILVX22.58-0.01
-0.04%
Harbor Large Cap Value Inv
CSMDX15.88-0.09
-0.56%
Copeland SMID Cap Dividend Growth I
AEIUX8.58-0.05
-0.58%
American Century Equity Income R5

HROW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-4.29%
AMRX - HROW
34%
Loosely correlated
-0.47%
ORGO - HROW
30%
Poorly correlated
-0.85%
RMTI - HROW
27%
Poorly correlated
-0.46%
EBS - HROW
26%
Poorly correlated
+6.36%
AMPH - HROW
25%
Poorly correlated
+0.31%
More